FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:292-294 July 15, 2004 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Alexander, E. K. PubMed Citation

Those with sufficiently long memories must be somewhat bemused by the successive controversies surrounding the treatment of primary hypothyroidism, a condition viewed by many as simple, satisfying to manage, and very much within the purview of the primary care physician, rather than the specialist. The development of sensitive assays for measuring thyrotropin has led to a reduction in levothyroxine doses; in most patients, a dose of only 100 to 125 µg daily restores serum thyrotropin levels to the reference range, thereby satisfying the 1990 recommendations of the American Thyroid Association,¹ which have since been reinforced.² There is no consensus, however, . . . [Full Text of this Article]

Source Information

From the Royal Infirmary, Edinburgh, Scotland.

This article has been cited by other articles:

• Wartofsky, L. (2005). Update in Endocrinology. ANN INTERN MED 143: 673-682 [Full Text]  
• Lazarus, J H, Premawardhana, L D K E (2005). BEST PRACTICE NO 184 Screening for thyroid disease in pregnancy. J. Clin. Pathol. 58: 449-452 [Abstract] [Full Text]